Pfizer



AMA Announces CPT Update for Pediatric COVID-19 Vaccine Candidate

The AMA announced that the CPT® code set has been updated by the CPT Editorial Panel. The provisional CPT codes will be effective for use on the condition that Pfizer’s two-dose regimen for the prevention of COVID-19 in children ages 5 to 11 receives approval or emergency use authorization from the FDA.